Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-01-09
4:06 pm
Purchase
13GKalVista Pharmaceuticals, Inc.
KALV
Venrock Healthcare Capital Partners III, L.P.2,916,667
8.6%
2,916,667increase
(New Position)
View
2022-12-23
4:15 pm
Purchase
13GCabaletta Bio, Inc.
CABA
Venrock Healthcare Capital Partners III, L.P.1,895,285
6.5%
1,895,285increase
(New Position)
View
2022-09-19
9:14 pm
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
Venrock Healthcare Capital Partners III, L.P.2,072,009
6.9%
2,072,009increase
(New Position)
View
2022-08-26
7:24 pm
Purchase
13GTerns Pharmaceuticals, Inc.
TERN
Venrock Healthcare Capital Partners III, L.P.3,066,241
8.2%
3,066,241increase
(New Position)
View
2022-02-14
4:19 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
Venrock Healthcare Capital Partners III, L.P.2,205,268
9.99%
262,213increase
(+13.49%)
View
2021-10-14
4:05 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
Venrock Healthcare Capital Partners III, L.P.1,943,055
9.99%
1,943,055increase
(New Position)
View
2021-02-16
4:11 pm
Purchase
13GTrillium Therapeutics Inc.
TRIL
Venrock Healthcare Capital Partners III, L.P.4,040,000
4%
1,250,000increase
(+44.80%)
View
2021-02-16
4:08 pm
Sale
13GGalera Therapeutics, Inc.
GRTX
Venrock Healthcare Capital Partners III, L.P.917,860
3.7%
-825,528decrease
(-47.35%)
View
2020-11-04
4:54 pm
Purchase
13GCardiff Oncology, Inc.
CRDF
Venrock Healthcare Capital Partners III, L.P.1,714,286
5.7%
1,714,286increase
(New Position)
View
2020-11-04
4:52 pm
Purchase
13GGalera Therapeutics, Inc.
GRTX
Venrock Healthcare Capital Partners III, L.P.1,743,388
7%
1,743,388increase
(New Position)
View
2020-01-21
4:52 pm
Purchase
13GTrillium Therapeutics Inc.
TRIL
Venrock Healthcare Capital Partners III, L.P.2,790,000
9.95%
2,790,000increase
(New Position)
View